The vaccination once morest Mpox (called that way since November) started this Monday (13) in all services in Brazil. In that sense, they are 47 mil doses of the immunizer that are available in the National Immunization Program (NIP). In addition, the idea is that two doses are applied to each person.
In this case, the focus of vaccination is on people who are at risk for the most serious forms of the disease. For example, laboratory professionals who work in places where the virus is exposed, as well as individuals living with HIV/AIDS. There are also recommendations established by the Ministry for both groups.
Pre-exposure to the virus
Those who live with HIV/AIDS and have an immunological status identified by a CD4 T lymphocyte count of less than 200 cells in the last six months will be able to receive the doses. According to the folder, there are 16,000 people across the country who fit this requirement.
The other group is formed by those who work in laboratories with level 3 biosafety, which operate directly with the Orthopoxvirus, which is the family of the monkeypox virus, between 18 and 49 years of age.
post-exposure to the virus
In this second aspect, those who had direct contact with secretions and body fluids of people with suspected disease, with exposure classified as high or medium risk according to WHO guidelines, can receive the doses.
Curiosity
21 Set
Tech
26 Ago
Anyone who has already been diagnosed with Mpox or has some type of suspicious lesion should not receive the vaccine when vaccinated. In addition, the Ministry of Health states that more doses will be made available according to the progress of vaccination and according to the requests of the states and the Federal District.
Still on vaccines, confirms news regarding the vaccine once morest dengue.
